Clinical Trials Directory

Trials / Completed

CompletedNCT02275546

Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)

A Multicenter, Open Label, Randomized, Two-period Crossover Study on the Insertion of MK-8342A (NuvaRing®) Placebo With and Without the Use of NuvaRing Applicator in Healthy Female Subjects

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
164 (actual)
Sponsor
Organon and Co · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to assess the performance and safe use of the vaginal ring applicator as an optional aid for insertion of a placebo vaginal ring into the vagina in healthy women

Conditions

Interventions

TypeNameDescription
DRUGPlacebo vaginal ringDrug-free placebo vaginal ring
DEVICESingle-use, non-sterile applicatorSingle-use, non-sterile, plastic applicator for insertion of vaginal ring.

Timeline

Start date
2014-12-11
Primary completion
2015-04-10
Completion
2015-04-10
First posted
2014-10-27
Last updated
2024-05-17
Results posted
2016-04-28

Source: ClinicalTrials.gov record NCT02275546. Inclusion in this directory is not an endorsement.